article thumbnail

FDA Programs to Support Advanced Manufacturing: Where Innovation Meets Regulation

The Premier Consulting Blog

With extensive experience in manufacturing techniques and regulations, the CMC services team at Premier Consulting can help sponsors navigate the development of advanced manufacturing technologies. FDA Guidance, Advanced Manufacturing Technologies Designation Program , December 2023, [link] [link]

FDA 52
article thumbnail

The Benefits of Integrated CDMO Services: Streamlining Drug Development and Manufacturing

Drug Patent Watch

from 2023 to 2030. ” – Patheon “By possessing a deeper understanding of the regulations that apply to each step of the development and manufacturing journey, embedded CDMOs can often anticipate questions and issues that might arise and help avoid costly delays.” 2023, August 31). References Patheon.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Understanding the Regulatory Environment in Japan for Generic Drug Development

Drug Patent Watch

Pharmaceutical Regulations in Japan 2020. Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis. Clinical Pharmacology & Therapeutics , 111(3), 531538. Freyr Solutions. 11 Must-know FAQs about the Drug Approval Process in Japan.

article thumbnail

The rising impact of biomarkers in early clinical development

Drug Target Review

For example, transcriptomic processes are showing the potential to identify and track failures in gene expression and gene regulation of amyloid and tau-related biomarkers, understood as precursors to the onset of Alzheimers disease (AD). Clinical Pharmacology and Therapeutics. Rodrigues AD.

article thumbnail

The future of CNS drug development: signs of real progress

Drug Target Review

Developers and sponsors working on biologically derived therapies in the US can utilise the Regenerative Medicine Advanced Therapy (RMAT) designation, which regulators grant to promising regenerative therapies. The blood–brain barrier: Structure, regulation and drug delivery. Sig Transduct Target Ther 8 , 217 (2023).

article thumbnail

Boosters and Biologics: Is Space-Based Biomanufacturing Real?

LifeSciVC

Regulators may reasonably ask is a drug crystallized in orbit the same as if made on Earth? Not Boring, 12 June 2023. Regardless, dedicated bioproduction facilities will be essential infrastructure, but the development, validation, production, and deployment of such systems is not guaranteed. Science vol. 246,4930 (1989): 651-4.

Science 96
article thumbnail

Overcoming challenges in biosimilar analytical characterization

Drug Patent Watch

This involves working closely with regulators to ensure that the analytical characterization and clinical trial design meet the necessary standards for approval. 2023, June 13). Collaboration with Regulatory Agencies : Collaboration with regulatory agencies such as the FDA and EMA is crucial in navigating the regulatory landscape.